Pociredir
6058-SCD-102
Phase 2 small_molecule active
Quick answer
Pociredir for Sickle Cell Disease is a Phase 2 program (small_molecule) at Fulcrum Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Fulcrum Therapeutics
- Indication
- Sickle Cell Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active